
VTGN
USDVistagen Therapeutics Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$4.180
Máximo
$4.296
Mínimo
$4.060
Volume
0.21M
Fundamentos da empresa
Capitalização de mercado
124.9M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
0.57M
Bolsa de valores
NCM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025
Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called
Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder
Topline results for the trial are expected by year end Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a
Ações relacionadas
WHLR
Wheeler Real Estate Investment Trust Inc.
PRFX
PainReform Ltd. Ordinary Shares
WSBCP
WesBanco Inc. Depositary Shares Each Representing a 1/40th Interest in a Share of 6.75% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
PAVM
PAVmed Inc.
BMY
Bristol-Myers Squibb Company
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.